Skip to main content

Table 2 Studies on relationship between quality of life data and survival in patients with lung cancer

From: Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008

Author(s)

Year

Sample

HRQOL measure(s)

Results*

Pater and Loeb [11]

1982

651 bronchogenic carcinoma

Symptomatic history, performance status, weight loss and age

Weight loss and performance status were significantly affected survival.

Kaasa et al. [14]

1989

102 inoperable non-small-cell, limited disease

Psychological well-being + disease-related symptoms + personal functioning + everyday activity

General symptoms and psychological well-being were the best predictive value for survival.

Ganz et al. [22]

1991

40 advanced metastatic lung cancer

FLI-C

A statistically significant relationship was observed between initial patient-rated QOL and subsequent survival.

Ruckdeschel et al. [23]

1994

438 lung cancer

FLI-C

Total FLI-C score was significant predictor of survival.

Loprinzi et al. [24]

1994

1,115 advanced colorectal or lung cancers

A designed patient-completed questionnaire

Patients' assessment of their own performance status and nutritional factors such as appetite, caloric intake, or overall food intake were prognostic of survival.

Buccheri et al. [25]

1995

128 Lung cancer

TIQ

The self-estimated difficulty at work and doing housework were significant independent prognostic determinants of survival.

Buccheri et al. [26]

1998

133 Lung cancer

SDS

Depression was associated with survival. Diverse SDS subscales were associated with survival.

Herndon et al. [27]

1999

206 advanced non-small-cell lung cancer

EORTC QLQ-C30 + Duke-UNC Social Support Scale

Pain was a significant predictor of survival but overall QOL was not.

Langendijk et al. [28]

2000

198 inoperable non-small-cell lung cancer

EORTC QLQ-C30

Global QOL was a strong prognostic factor of survival.

Burrows et al. [29]

2000

85 recurrent symptomatic malignant pleural effusions

KPS

Only the KPS score (score ≥ 70) at the time of thoracoscopy was predictive of survival. Pleural fluid pH, pleural fluid glucose, and EPC scores were not as reliable as initially reported.

Montazeri et al. [30]

2001

129 lung cancer (small and non-small-cell)

NHP + EORTC QLQ-C30 + EORTC QLQ-LC13

Baseline global QOL was most significant predictor of the length of survival.

Auchter et al. [31]

2001

30 non-small cell lung cancer

FACT-L (TOI)

The change in TOI score was not associated with survival. A trend was noted for shorter survival with the largest negative change in TOI score.

Moinpour et al. [32]

2002

222 advanced non-small-cell

FACT-L

Total FACT-L score was predictor of survival.

Nakahara et al. [33]

2002

179 advanced small- and non-small cell lung cancer

Tokyo University Egogram (measure for mental state)

Mental state was prognostic of survival.

Naughton et al. [34]

2002

70 small-cell lung cancer

EORTC QLQ-C30 + CES-D + MOS Social Support Questionnaire + a sleep quality scale

Higher depressive symptoms were borderline significant in predicting decreased survival.

Eton et al. [35]

2003

573 advanced non-small-cell lung cancer

FACT-L + TOI

Baseline physical well-being and TOI scores predicted either survival duration or disease progression respectively.

Dharma-Wardene et al. [36]

2004

44 advanced lung cancer

FACT-G

Baseline FACT-G total score was significantly associated with survival.

Nowak et al. [37]

2004

53 pleural mesothelomia

EORTC QLQ-C30 + EORTC QLQ-LC13

Functional domains and symptom scales (fatigue and pain) demonstrated predictive validity for survival.

Maione et al. [38]

2005

566 advanced non-small-cell lung cancer

ADL + IADL + EORTC QOL-C30 (global QOL)

Baseline global QOL and IADL were significant prognostic factors for overall survival.

Brown et al. [39]

2005

273 non-small-cell lung cancer

EORTC QLQ-C30 + EORTC QLQ-LC17 + DDC

Global QOL, role functioning, fatigue, appetite loss and constipation were prognostic indicators of survival.

Martins et al. [40]

2005

41 locally advanced or metastatic lung cancer

LCSS

Patients' scores on the LCSS appetite and fatigue subscales were independent predictors of survival.

Efficace et al. [41]

2006

391 advanced non-small-cell lung cancer

EORTC QLQ-C30 + EORTC QLQ-LC13

Pain, and dysphagia were significant prognostic factors for survival.

Sundstrom et al. [42]

2006

301 stag III non-small-cell lung cancer

EORTC QLQ-C30

Appetite loss was the most significant prognostic factor of survival.

Bottomley et al. [43]

2007

250 malignant pleural mesothelioma

EORTC QLQ-C30 + EORTC QLQ-LC13

Pain, and appetite loss were independent prognostic indicators of survival.

Fielding and Wong [44]

2007

534 liver and lung cancers

FACT-G

Global QOL scores did not predict survival in liver and lung cancer. Physical well-being and appetite predicted survival in lung cancer.

Jacot et al. [45]

2008

301 non-small-cell lung cancer

LCSS

Pretreatment LCSS global symptoms score was independent determinant of overall survival.

  1. Abbreviations: CES-D: Centre for Epidemiologic Studies-Depression Scale; DDC: Daily Diary Card; EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire; EORTC QLQ-LC13 (or QLQ LC17): EORTC Lung Cancer specific Quality of Life Questionnaire (previously containing 17items); FACT-G: Functional Assessment of Cancer Therapy-General module; FACT-L: Functional Assessment of Cancer Therapy-Lung module; FLI-C: Functional Living Index-Cancer; IADL: Instrumental Activities of Daily Living; KPS: Karnofsky Performance Status; LCSS: Lung Cancer Symptoms Scale; MOS: Medical Outcomes Study; ADL: Activities of Daily Living; NHP: Nottingham Health Profile; QOL: quality of life; SDS: Self-rating Depression Scale; TIQ: Therapy Impact Questionnaire; TOI: Trial Outcome Index.
  2. * All results obtained from multivariate analyses after controlling for one or more demographic and known biomedical prognostic factors.